Status:
UNKNOWN
Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
University Hospital, Akershus
Vestre Viken Hospital Trust
Conditions:
SARS Virus
Severe Acute Respiratory Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Oslo University Hospital has initiated an observational study on hospitalised patients with confirmed COVID-19, the infection caused by Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2...
Detailed Description
Infectious disease is the single biggest cause of death worldwide. New infectious agents, such as the SARS-CoV-2, require investigation to understand pathogen biology and pathogenesis in the host. In ...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 by screening of SARS-CoV-2 E-gene
Exclusion
- Refusal of consent by patient or closest relative
Key Trial Info
Start Date :
March 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04381819
Start Date
March 2 2020
End Date
December 31 2023
Last Update
May 11 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Vestre Viken Drammen Hospital
Drammen, Akershus, Norway, 3000
2
Haukeland University Hospital
Bergen, Norway, 5021
3
Østfold Hospital Trust
Fredrikstad, Norway, 1714
4
Akershus University Hospital
Lørenskog, Norway, 1478